Literature DB >> 2000894

Neuromuscular disease of the gastrointestinal tract.

S Chokhavatia1, S Anuras.   

Abstract

Gastrointestinal motility is the function of gastrointestinal smooth muscle. It is controlled by both the intrinsic and extrinsic nerves of the gastrointestinal tract and, to a lesser degree, the gastrointestinal hormones. Therefore, any abnormality of the above factors, theoretically, can cause gastrointestinal dysmotility. In a clinical situation, commonly seen is gastrointestinal dysmotility caused by either smooth muscle or intrinsic and extrinsic nerves dysfunction. Diseases that cause smooth muscle dysfunction include familial visceral myopathies, nonfamilial visceral myopathies, collagen disease, muscular dystrophies, amyloidosis, thyroid disease, and so on. Diseases that cause enteric nerve dysfunction include familial visceral neuropathies, nonfamilial visceral neuropathies, diabetes mellitus, Chagas' disease, ganglioneuromatosis of the intestine, visceral neuropathy of carcinomatosis, Parkinson's disease, and so on. The patients with neuromuscular disease of the gastrointestinal tract have a wide range of clinical manifestations regardless of the underlying cause. At one end of the spectrum, the patients may be asymptomatic, and at the other end of the spectrum, the patients may have functional obstruction of the gastrointestinal tract. Plain abdominal x-rays, upper gastrointestinal (UGI) and small bowel x-rays, enteroclysis, barium enema, and manometric studies are useful for the work-up of these patients. Enteroclysis is especially helpful in ruling out mechanical obstruction of the small intestine in patients with chronic intestinal pseudo-obstruction. Treatment is mainly symptomatic and supportive. There is no effective drug to improve gastrointestinal motility. Surgery may be helpful in selected cases of severe gastrointestinal dysmotility.

Entities:  

Mesh:

Year:  1991        PMID: 2000894     DOI: 10.1097/00000441-199103000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

1.  Effect of leuprolide acetate in patients with functional bowel disease. Long-term follow-up after double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; P H Roberts; V G Reeves-Darby
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

2.  Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction.

Authors:  K Hiramatsu; S Kaneko; Y Shirota; M Matsuda; K Kaji; Y Kitano; N Ikeda; S Terasaki; H Kawai; A Shimoda; H Yokoyama; E Matsushita; T Urabe; K Kobayashi
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

3.  Skin-derived precursors generate enteric-type neurons in aganglionic jejunum.

Authors:  Justin P Wagner; Veronica F Sullins; James C Y Dunn
Journal:  J Pediatr Surg       Date:  2014-10-01       Impact factor: 2.545

4.  Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; V G Reeves-Darby; L M Fox; P H Hsu; P H Roberts; L L Smith; N J Stiglich
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

5.  Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate.

Authors:  J R Mathias; G S Baskin; V G Reeves-Darby; M H Clench; L L Smith; J H Calhoon
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

6.  A novel in vivo model of permanent intestinal aganglionosis.

Authors:  Justin P Wagner; Veronica F Sullins; James C Y Dunn
Journal:  J Surg Res       Date:  2014-06-13       Impact factor: 2.192

7.  Misato underlies visceral myopathy in Drosophila.

Authors:  Soohong Min; Woongchang Yoon; Hyunho Cho; Jongkyeong Chung
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

8.  Technique of functional and motility test: how to perform antroduodenal manometry.

Authors:  Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.